The tariff classification of Metoprolol Succinate Extended Release Tablets in dosage form, from India
Issued July 6, 2023 by U.S. Customs and Border Protection.
Tariff classification
HTS codes: 3004.90.9220
Headings: 3004
Product description
Metoprolol Succinate, imported in 25 mg, 50 mg, 100 mg and 200 mg extended release tablets, is a selective ß1 receptor blocker. It is indicated for the treatment of hypertension and angina.
CBP rationale
The applicable subheading for the Metoprolol Succinate Extended Release Tablets in dosage form will be 3004.90.9220, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Medicaments … consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses … or in forms or packings for retail sale: Other: Other: Other: Cardiovascular medicaments.
Full text
N333473 July 6, 2023 CLA-2-30:OT:RR:NC:N3:138 CATEGORY: Classification TARIFF NO.: 3004.90.9220 Liam O'Connor NorthStar Healthcare 3300 Cork Airport Business Park Kinsale Road, Cork Ireland RE: The tariff classification of Metoprolol Succinate Extended Release Tablets in dosage form, from India Dear Mr. O'Connor: In your letter dated June 12, 2023, you requested a tariff classification ruling. Metoprolol Succinate, imported in 25 mg, 50 mg, 100 mg and 200 mg extended release tablets, is a selective ß1 receptor blocker. It is indicated for the treatment of hypertension and angina. The applicable subheading for the Metoprolol Succinate Extended Release Tablets in dosage form will be 3004.90.9220, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Medicaments … consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses … or in forms or packings for retail sale: Other: Other: Other: Cardiovascular medicaments.” The rate of duty will be free. Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided at https://hts.usitc.gov/current. This merchandise may be subject to the Federal Food, Drug, and Cosmetic Act and/or The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (The Bioterrorism Act), which are administered by the U.S. Food and Drug Administration (FDA). Information on the Federal Food, Drug, and Cosmetic Act, as well as The Bioterrorism Act, can be obtained by calling the FDA at 1-888-463-6332, or by visiting their website at www.fda.gov. This ruling is being issued under the provisions of Part 177 of the Customs and Border Protection Regulations (19 C.F.R. 177). A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, please contact National Import Specialist Judy Lee at [email protected]. Sincerely, Steven A. Mack Director National Commodity Specialist Division
More rulings on the same tariff codes
The tariff classification of Clonidine Hydrochloride Extended-Release Tablets in dosage form, from India
The tariff classification of Enoxaparin Sodium Injection in dosage form, from China
The tariff classification of Enoxaparin Sodium Injection in dosage form, from China
The tariff classification of Scopolamine Transdermal System from Australia and Pitavastatin Tablets from India
The tariff classification of Labetalol Hydrochloride Injection in dosage form, from Italy
The tariff classification of Icosapent Ethyl Capsules in dosage form, from China, and the classification of Norelgestromin and Ethinyl Estradiol Transdermal System from Argentina and India
The tariff classification of Dofetilide Capsules in dosage form, from India
The tariff classification of Isosorbide Dinitrate Tablets in dosage form, from India
The tariff classification of Clopidogrel Bisulfate Tablets in dosage form, from India
The tariff classification of Diltiazem Hydrochloride ER Capsules in dosage form, from India
Searching CBP rulings the smart way
TariffLens semantically searches all 200,000+ CBP rulings, surfaces the ones that actually match your product, and builds defensible classifications backed by ruling citations.
Book a demo →